2025-09-08 |
13G
|
KZR / Kezar Life Sciences, Inc.
|
|
|
377,240 |
|
|
|
2025-08-13 |
13G/A
|
AYTU / Aytu BioPharma, Inc.
|
|
626,862 |
906,063 |
|
|
|
2025-08-13 |
13G/A
|
SRZN / Surrozen, Inc.
|
|
332,451 |
508,687 |
|
|
|
2025-08-06 |
13G
|
VSTM / Verastem, Inc.
|
|
2,203,333 |
2,833,333 |
|
|
|
2025-05-14 |
13G/A
|
SRZN / Surrozen, Inc.
|
|
244,658 |
332,451 |
|
|
|
2025-05-14 |
13G/A
|
OPTN / OptiNose, Inc.
|
|
588,657 |
788,647 |
|
|
|
2025-05-14 |
13G/A
|
INO / Inovio Pharmaceuticals, Inc.
|
|
1,916,666 |
1,434,997 |
|
|
|
2025-05-14 |
13G/A
|
CALC / CalciMedica, Inc.
|
|
741,701 |
628,672 |
|
|
|
2025-05-14 |
13G/A
|
APRE / Aprea Therapeutics, Inc.
|
|
286,395 |
239,416 |
|
|
|
2025-02-25 |
13G
|
EDSA / Edesa Biotech, Inc.
|
|
|
693,551 |
|
|
|
2025-02-13 |
13G/A
|
OPTN / OptiNose, Inc.
|
|
|
588,657 |
|
|
|
2025-02-13 |
13G/A
|
VSTM / Verastem, Inc.
|
|
2,643,620 |
2,203,333 |
|
|
|
2025-02-13 |
13G/A
|
APRE / Aprea Therapeutics, Inc.
|
|
365,436 |
286,395 |
|
|
|
2025-02-13 |
13G/A
|
TELA / TELA Bio, Inc.
|
|
2,831,839 |
2,353,099 |
|
|
|
2024-12-23 |
13G
|
INO / Inovio Pharmaceuticals, Inc.
|
|
|
1,916,666 |
|
|
|
2024-12-13 |
13G
|
CALC / CalciMedica, Inc.
|
|
0 |
741,701 |
|
|
|
2024-11-20 |
13G
|
OPTN / OptiNose, Inc.
|
|
|
8,174,631 |
|
|
|
2024-11-13 |
13G/A
|
SRZN / Surrozen, Inc.
|
|
199,158 |
244,658 |
|
|
|
2024-11-13 |
13G/A
|
VSTM / Verastem, Inc.
|
|
2,666,666 |
2,643,620 |
|
|
|
2024-11-13 |
13G/A
|
EOLS / Evolus, Inc.
|
|
5,333,004 |
1,369,821 |
|
|
|
2024-11-13 |
13G/A
|
AYTU / Aytu BioPharma, Inc.
|
|
565,484 |
626,862 |
|
|
|
2024-11-13 |
13G/A
|
TENX / Tenax Therapeutics, Inc.
|
|
372,797 |
372,797 |
|
|
|
2024-11-13 |
13G/A
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
2,409,058 |
307,229 |
|
|
|
2024-11-13 |
13G/A
|
CALC / CalciMedica, Inc.
|
|
1,045,204 |
0 |
|
|
|
2024-11-13 |
13G/A
|
RZLT / Rezolute, Inc.
|
|
2,768,656 |
0 |
|
|
|
2024-11-13 |
13G/A
|
ALIM / Alimera Sciences, Inc.
|
|
5,373,732 |
0 |
|
|
|
2024-11-13 |
13G/A
|
IOBT / IO Biotech, Inc.
|
|
3,641,345 |
0 |
|
|
|
2024-10-29 |
13G
|
TELA / TELA Bio, Inc.
|
|
|
2,831,839 |
|
|
|
2024-10-10 |
13G
|
APRE / Aprea Therapeutics, Inc.
|
|
|
365,436 |
|
|
|
2024-08-15 |
13G
|
TENX / Tenax Therapeutics, Inc.
|
|
|
372,797 |
|
|
|
2024-07-29 |
13G
|
VSTM / Verastem, Inc.
|
|
|
2,666,666 |
|
|
|
2024-04-19 |
13G
|
SRZN / Surrozen, Inc.
|
|
|
199,158 |
|
|
|
2024-02-13 |
13G/A
|
URGN / UroGen Pharma Ltd.
|
|
1,304,947 |
0 |
|
|
|
2024-02-13 |
13G/A
|
XGN / Exagen Inc.
|
|
854,042 |
669,684 |
|
|
|
2024-02-13 |
13G/A
|
XERS / Xeris Biopharma Holdings, Inc.
|
|
11,195,189 |
5,937,000 |
|
|
|
2024-02-13 |
13G/A
|
THRD / Third Harmonic Bio, Inc.
|
|
2,152,968 |
0 |
|
|
|
2024-02-13 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
2,777,877 |
1,355,186 |
|
|
|
2024-02-13 |
13G/A
|
ATYR / aTyr Pharma, Inc.
|
|
4,743,162 |
482,258 |
|
|
|
2024-02-13 |
13G/A
|
RZLT / Rezolute, Inc.
|
|
3,021,504 |
2,768,656 |
|
|
|
2024-02-13 |
13G/A
|
IOBT / IO Biotech, Inc.
|
|
3,950,616 |
3,641,345 |
|
|
|
2024-02-13 |
13G/A
|
GMDAQ / Gamida Cell Ltd.
|
|
9,854,158 |
3,000,000 |
|
|
|
2024-02-13 |
13G/A
|
EOLS / Evolus, Inc.
|
|
4,187,447 |
5,333,004 |
|
|
|
2024-02-13 |
13G/A
|
DCTH / Delcath Systems, Inc.
|
|
976,008 |
208,333 |
|
|
|
2024-02-13 |
13G/A
|
AYTU / Aytu BioPharma, Inc.
|
|
563,842 |
565,484 |
|
|
|
2024-02-13 |
13G/A
|
ALIM / Alimera Sciences, Inc.
|
|
5,377,711 |
5,373,732 |
|
|
|
2024-02-09 |
13G
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
|
2,409,058 |
|
|
|
2024-01-31 |
13G
|
CALC / CalciMedica, Inc.
|
|
|
1,045,204 |
|
|
|
2023-08-24 |
13G
|
GMDAQ / Gamida Cell Ltd.
|
|
|
9,854,158 |
|
|
|
2023-08-16 |
13G
|
IOBT / IO Biotech, Inc.
|
|
|
3,950,616 |
|
|
|
2023-08-10 |
13G
|
ALIM / Alimera Sciences, Inc.
|
|
0 |
5,377,711 |
|
|
|
2023-06-26 |
13G
|
DCTH / Delcath Systems, Inc.
|
|
|
976,008 |
|
|
|
2023-06-16 |
13G
|
EOLS / Evolus, Inc.
|
|
|
4,187,447 |
|
|
|
2023-06-16 |
13G
|
AYTU / Aytu BioPharma, Inc.
|
|
|
563,842 |
|
|
|
2023-06-09 |
13G
|
SCYX / SCYNEXIS, Inc.
|
|
385,650 |
2,777,877 |
|
|
|
2023-05-01 |
13G
|
ATYR / aTyr Pharma, Inc.
|
|
4,569,433 |
4,743,162 |
|
|
|
2023-04-13 |
13G
|
CTIC / CTI BioPharma Corp
|
|
5,664,100 |
7,018,046 |
|
|
|
2023-02-17 |
13G/A
|
ATYR / aTyr Pharma, Inc.
|
|
|
4,569,433 |
|
|
|
2023-02-13 |
13G/A
|
XERS / Xeris Biopharma Holdings, Inc.
|
|
6,491,099 |
11,195,189 |
|
|
|
2023-02-13 |
13G/A
|
XGN / Exagen Inc.
|
|
858,567 |
854,042 |
|
|
|
2023-02-13 |
13G/A
|
URGN / UroGen Pharma Ltd.
|
|
1,196,908 |
1,304,947 |
|
|
|
2023-02-13 |
13G/A
|
US20717E2000 / CONFORMIS INC
|
|
|
748,194 |
|
|
|
2023-02-13 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
9,911,577 |
6,940,000 |
|
|
|
2023-02-13 |
13G/A
|
APEN / Apollo Endosurgery Inc
|
|
2,655,129 |
4,351,088 |
|
|
|
2023-02-13 |
13G/A
|
RZLT / Rezolute, Inc.
|
|
808,405 |
3,021,504 |
|
|
|
2023-02-13 |
13G/A
|
OVID / Ovid Therapeutics Inc.
|
|
4,006,185 |
0 |
|
|
|
2023-02-13 |
13G/A
|
CTIC / CTI BioPharma Corp
|
|
9,754,935 |
5,664,100 |
|
|
|
2023-02-13 |
13G/A
|
US03217L1061 / Amryt Pharma PLC Sponsored ADR (United Kingdom)
|
|
30,348,875 |
31,666,195 |
|
|
|
2023-01-19 |
13G
|
THRD / Third Harmonic Bio, Inc.
|
|
|
2,152,968 |
|
|
|
2022-12-01 |
13G
|
URGN / UroGen Pharma Ltd.
|
|
|
1,196,908 |
|
|
|
2022-02-14 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
9,972,877 |
9,911,577 |
|
|
|
2022-02-14 |
13G/A
|
CTIC / CTI BioPharma Corp
|
|
8,148,420 |
9,754,935 |
|
|
|
2022-02-14 |
13G/A
|
XGN / Exagen Inc.
|
|
833,537 |
858,567 |
|
|
|
2022-02-14 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
1,530,650 |
385,650 |
|
|
|
2022-02-14 |
13G/A
|
OVID / Ovid Therapeutics Inc.
|
|
3,500,000 |
4,006,185 |
|
|
|
2022-02-14 |
13G/A
|
CBIO / Crescent Biopharma, Inc.
|
|
2,144,812 |
0 |
|
|
|
2022-02-14 |
13G/A
|
YMTX / Yumanity Therapeutics Inc
|
|
643,620 |
0 |
|
|
|
2022-02-14 |
13G/A
|
CFMS / Conformis Inc.
|
|
9,161,871 |
14,768,823 |
|
|
|
2022-02-14 |
13G/A
|
RZLT / Rezolute, Inc.
|
|
789,326 |
808,405 |
|
|
|
2022-02-14 |
13G/A
|
APEN / Apollo Endosurgery Inc
|
|
2,603,480 |
2,655,129 |
|
|
|
2022-02-14 |
13G/A
|
ADMS / Adamas Pharmaceuticals Inc
|
|
3,408,849 |
0 |
|
|
|
2022-02-11 |
13G/A
|
AGTC / Applied Genetic Technologies Corp
|
|
2,273,876 |
0 |
|
|
|
2022-02-11 |
13G/A
|
AYTU / Aytu BioPharma, Inc.
|
|
1,398,776 |
0 |
|
|
|
2022-02-11 |
13G/A
|
US03217L1061 / Amryt Pharma PLC Sponsored ADR (United Kingdom)
|
|
11,082,415 |
30,348,875 |
|
|
|
2022-02-11 |
13G/A
|
DMAC / DiaMedica Therapeutics Inc.
|
|
1,150,259 |
1,394,929 |
|
|
|
2022-01-14 |
13G
|
XERS / Xeris Biopharma Holdings, Inc.
|
|
6,491,099 |
6,491,099 |
|
|
|
2021-12-30 |
13G
|
ADMA / ADMA Biologics, Inc.
|
|
|
9,972,877 |
|
|
|
2021-12-27 |
13G
|
RZLT / Rezolute, Inc.
|
|
789,326 |
789,326 |
|
|
|
2021-12-27 |
13G
|
XGN / Exagen Inc.
|
|
833,537 |
833,537 |
|
|
|
2021-11-19 |
13G
|
YMTX / Yumanity Therapeutics Inc
|
|
|
643,620 |
|
|
|
2021-08-09 |
13G/A
|
US16706W1027 / Chiasma Inc
|
|
6,770,000 |
0 |
|
|
|
2021-07-09 |
13G
|
SBBP / Strongbridge Biopharma plc
|
|
|
3,566,964 |
|
|
|
2021-06-14 |
13G
|
CFMS / Conformis Inc.
|
|
0 |
9,161,871 |
|
|
|
2021-05-14 |
13G/A
|
US16706W1027 / Chiasma Inc
|
|
3,862,483 |
6,770,000 |
|
|
|
2021-04-29 |
13G
|
OVID / Ovid Therapeutics Inc.
|
|
|
3,500,000 |
|
|
|
2021-03-18 |
13G
|
US16706W1027 / Chiasma Inc
|
|
3,862,483 |
3,862,483 |
|
|
|
2021-03-18 |
13G
|
US16706W1027 / Chiasma Inc
|
|
3,862,483 |
3,862,483 |
|
|
|
2021-03-02 |
13G
|
ADMS / Adamas Pharmaceuticals Inc
|
|
3,408,849 |
3,408,849 |
|
|
|
2021-03-02 |
13G
|
ADMS / Adamas Pharmaceuticals Inc
|
|
808,431 |
3,408,849 |
|
|
|
2021-02-19 |
13G/A
|
CBIO / Crescent Biopharma, Inc.
|
|
834,449 |
2,144,812 |
|
|
|
2021-02-12 |
13G/A
|
ADMS / Adamas Pharmaceuticals Inc
|
|
2,241,239 |
808,431 |
|
|
|
2021-02-12 |
13G/A
|
AYTU / Aytu BioPharma, Inc.
|
|
1,333,334 |
1,398,776 |
|
|
|
2021-02-12 |
13G/A
|
HTGM / HTG Molecular Diagnostics Inc
|
|
5,913,812 |
0 |
|
|
|
2021-02-12 |
13G/A
|
IDXG / Interpace Biosciences, Inc.
|
|
277,277 |
0 |
|
|
|
2021-02-12 |
13G/A
|
OPNT / Opiant Pharmaceuticals Inc
|
|
334,272 |
0 |
|
|
|
2021-02-12 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
1,536,953 |
1,530,650 |
|
|
|
2021-02-12 |
13G/A
|
APVO / Aptevo Therapeutics Inc.
|
|
4,561,605 |
18,280 |
|
|
|
2021-02-12 |
13G/A
|
US64052L1061 / Neos Therapeutics, Inc.
|
|
4,858,889 |
4,962,657 |
|
|
|
2021-02-12 |
13G/A
|
ISEE / IVERIC bio Inc
|
|
5,147,744 |
800,000 |
|
|
|
2021-02-12 |
13G/A
|
DMAC / DiaMedica Therapeutics Inc.
|
|
800,000 |
1,150,259 |
|
|
|
2021-02-12 |
13G/A
|
CDTX / Cidara Therapeutics, Inc.
|
|
2,054,048 |
0 |
|
|
|
2021-02-12 |
13G/A
|
CPIX / Cumberland Pharmaceuticals Inc.
|
|
896,170 |
188,703 |
|
|
|
2021-02-12 |
13G/A
|
CBIO / Crescent Biopharma, Inc.
|
|
1,039,235 |
834,449 |
|
|
|
2021-02-12 |
13G/A
|
BXRX / Baudax Bio, Inc.
|
|
1,819,849 |
0 |
|
|
|
2021-02-12 |
13G/A
|
AFMD / Affimed N.V.
|
|
4,010,155 |
219,340 |
|
|
|
2021-02-12 |
13G/A
|
APEN / Apollo Endosurgery Inc
|
|
2,141,279 |
2,603,480 |
|
|
|
2021-02-12 |
13G/A
|
US03217L1061 / Amryt Pharma PLC Sponsored ADR (United Kingdom)
|
|
|
11,082,415 |
|
|
|
2021-02-12 |
13G/A
|
CTIC / CTI BioPharma Corp
|
|
3,613,600 |
8,148,420 |
|
|
|
2021-02-08 |
13G
|
AGTC / Applied Genetic Technologies Corp
|
|
2,273,876 |
2,273,876 |
|
|
|
2021-02-08 |
13G
|
AGTC / Applied Genetic Technologies Corp
|
|
2,273,876 |
2,273,876 |
|
|
|
2020-12-23 |
13G
|
SCYX / SCYNEXIS, Inc.
|
|
568,450 |
1,536,953 |
|
|
|
2020-12-17 |
13G
|
AYTU / Aytu BioPharma, Inc.
|
|
1,333,334 |
1,333,334 |
|
|
|
2020-12-17 |
13G
|
AYTU / Aytu BioPharma, Inc.
|
|
1,333,334 |
1,333,334 |
|
|
|
2020-09-11 |
13G
|
IDXG / Interpace Biosciences, Inc.
|
|
107,760 |
277,277 |
|
|
|
2020-08-05 |
13G
|
CBIO / Crescent Biopharma, Inc.
|
|
1,039,235 |
1,039,235 |
|
|
|
2020-04-17 |
13G
|
IDXG / Interpace Biosciences, Inc.
|
|
|
107,760 |
|
|
|
2020-04-02 |
13G
|
BXRX / Baudax Bio, Inc.
|
|
|
1,819,849 |
|
|
|
2020-03-12 |
13G
|
CBIO / Crescent Biopharma, Inc.
|
|
|
1,039,235 |
|
|
|
2020-02-21 |
13G
|
CDTX / Cidara Therapeutics, Inc.
|
|
|
2,054,048 |
|
|
|
2020-02-13 |
13G/A
|
BDSI / Biodelivery Sciences International
|
|
3,981,867 |
0 |
|
|
|
2020-02-13 |
13G/A
|
ATXS / Astria Therapeutics, Inc.
|
|
758,333 |
390,000 |
|
|
|
2020-02-13 |
13G/A
|
CTIC / CTI BioPharma Corp
|
|
5,726,579 |
3,613,600 |
|
|
|
2020-02-13 |
13G/A
|
CPIX / Cumberland Pharmaceuticals Inc.
|
|
1,313,429 |
896,170 |
|
|
|
2020-02-13 |
13G/A
|
HTGM / HTG Molecular Diagnostics Inc
|
|
2,675,889 |
5,913,812 |
|
|
|
2020-02-13 |
13G/A
|
US64052L1061 / Neos Therapeutics, Inc.
|
|
4,210,153 |
4,858,889 |
|
|
|
2020-02-13 |
13G/A
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
3,703,420 |
3,909,207 |
|
|
|
2020-02-13 |
13G/A
|
OPNT / Opiant Pharmaceuticals Inc
|
|
357,960 |
334,272 |
|
|
|
2020-02-13 |
13G/A
|
ISEE / IVERIC bio Inc
|
|
|
5,147,744 |
|
|
|
2020-02-13 |
13G/A
|
AFMD / Affimed N.V.
|
|
4,593,022 |
4,010,155 |
|
|
|
2020-02-13 |
13G/A
|
APEN / Apollo Endosurgery Inc
|
|
2,580,518 |
2,141,279 |
|
|
|
2020-02-13 |
13G/A
|
APVO / Aptevo Therapeutics Inc.
|
|
4,273,862 |
4,561,605 |
|
|
|
2020-02-13 |
13G/A
|
ALIM / Alimera Sciences, Inc.
|
|
6,547,774 |
0 |
|
|
|
2020-02-13 |
13G/A
|
ADMS / Adamas Pharmaceuticals Inc
|
|
1,515,552 |
2,241,239 |
|
|
|
2020-02-12 |
13G
|
DMAC / DiaMedica Therapeutics Inc.
|
|
800,000 |
800,000 |
|
|
|
2020-02-11 |
13G
|
DMAC / DiaMedica Therapeutics Inc.
|
|
|
800,000 |
|
|
|
2019-12-16 |
13G
|
AFMD / Affimed N.V.
|
|
4,593,022 |
4,593,022 |
|
|
|
2019-12-13 |
13G
|
AFMD / Affimed N.V.
|
|
|
4,593,022 |
|
|
|
2019-10-02 |
13G/A
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
1,155,085 |
3,703,420 |
|
|
|
2019-08-23 |
13G
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
531,662 |
1,155,085 |
|
|
|
2019-07-23 |
13D/A
|
VIVE / Viveve Medical, Inc.
|
|
3,907,513 |
57,802 |
|
|
|
2019-06-19 |
13G
|
ADMS / Adamas Pharmaceuticals Inc
|
|
|
1,515,552 |
|
|
|
2019-03-18 |
13G
|
APVO / Aptevo Therapeutics Inc.
|
|
|
4,273,862 |
|
|
|
2019-02-14 |
13G/A
|
APEN / Apollo Endosurgery Inc
|
|
2,560,314 |
2,580,518 |
|
|
|
2019-02-13 |
13G/A
|
BDSI / Biodelivery Sciences International
|
|
3,981,867 |
3,981,867 |
|
|
|
2019-02-13 |
13G/A
|
ALIM / Alimera Sciences, Inc.
|
|
3,559,899 |
6,547,774 |
|
|
|
2019-02-13 |
13G/A
|
CEMP / Cempra, Inc.
|
|
3,474,761 |
0 |
|
|
|
2019-02-13 |
13G/A
|
US0909311062 / BioSpecifics Technologies Corp.
|
|
385,954 |
217,395 |
|
|
|
2019-02-13 |
13G/A
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
1,694,717 |
531,662 |
|
|
|
2019-02-13 |
13G/A
|
US64052L1061 / Neos Therapeutics, Inc.
|
|
4,637,169 |
4,210,153 |
|
|
|
2019-02-13 |
13G/A
|
ATEC / Alphatec Holdings, Inc.
|
|
1,733,534 |
1,147,802 |
|
|
|
2019-02-13 |
13G/A
|
VYNT / Vyant Bio, Inc.
|
|
1,786,063 |
0 |
|
|
|
2019-02-13 |
13G/A
|
HTGM / HTG Molecular Diagnostics Inc
|
|
1,450,000 |
2,675,889 |
|
|
|
2019-02-13 |
13G/A
|
CFMS / Conformis Inc.
|
|
3,357,803 |
0 |
|
|
|
2019-02-13 |
13G/A
|
ATXS / Astria Therapeutics, Inc.
|
|
4,800,000 |
758,333 |
|
|
|
2019-02-13 |
13G/A
|
CORV / Correvio Pharma Corp. (Canada)
|
|
|
424,101 |
|
|
|
2019-02-13 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
2,923,987 |
568,450 |
|
|
|
2019-02-13 |
13G/A
|
CTIC / CTI BioPharma Corp
|
|
2,150,000 |
5,726,579 |
|
|
|
2019-02-13 |
13G/A
|
OPNT / Opiant Pharmaceuticals Inc
|
|
199,368 |
357,960 |
|
|
|
2019-02-13 |
13G/A
|
ISEE / IVERIC bio Inc
|
|
2,350,000 |
4,072,301 |
|
|
|
2019-02-13 |
13G/A
|
CPIX / Cumberland Pharmaceuticals Inc.
|
|
1,306,911 |
1,313,429 |
|
|
|
2019-02-12 |
13G/A
|
BDSI / Biodelivery Sciences International
|
|
3,645,491 |
3,981,867 |
|
|
|
2018-12-11 |
13D/A
|
VIVE / Viveve Medical, Inc.
|
|
3,905,101 |
3,907,513 |
|
|
|
2018-11-08 |
13G
|
US64052L1061 / Neos Therapeutics, Inc.
|
|
|
4,637,169 |
|
|
|
2018-11-02 |
13G
|
CEMP / Cempra, Inc.
|
|
|
3,474,761 |
|
|
|
2018-10-25 |
13G
|
SCYX / SCYNEXIS, Inc.
|
|
|
2,923,987 |
|
|
|
2018-10-09 |
13G
|
OPNT / Opiant Pharmaceuticals Inc
|
|
|
199,368 |
|
|
|
2018-09-14 |
13D/A
|
VIVE / Viveve Medical, Inc.
|
|
3,873,567 |
3,905,101 |
|
|
|
2018-06-28 |
13G
|
ATXS / Astria Therapeutics, Inc.
|
|
|
4,800,000 |
|
|
|
2018-06-15 |
13G
|
ATEC / Alphatec Holdings, Inc.
|
|
|
1,733,534 |
|
|
|
2018-05-11 |
13G
|
STDY / SteadyMed Ltd.
|
|
|
1,381,651 |
|
|
|
2018-03-21 |
13G/A
|
REPH / Societal CDMO Inc
|
|
1,050,115 |
94,182 |
|
|
|
2018-02-13 |
13G/A
|
ALIM / Alimera Sciences, Inc.
|
|
4,615,813 |
3,559,899 |
|
|
|
2018-02-13 |
13G/A
|
APEN / Apollo Endosurgery Inc
|
|
2,364,707 |
2,560,314 |
|
|
|
2018-02-13 |
13G/A
|
BDSI / Biodelivery Sciences International
|
|
3,228,493 |
3,645,491 |
|
|
|
2018-02-13 |
13G/A
|
US0909311062 / BioSpecifics Technologies Corp.
|
|
375,000 |
385,954 |
|
|
|
2018-02-13 |
13G/A
|
VYNT / Vyant Bio, Inc.
|
|
1,396,205 |
1,786,063 |
|
|
|
2018-02-13 |
13G/A
|
CRME / Cardiome Pharma Corp.
|
|
3,158,816 |
3,195,692 |
|
|
|
2018-02-13 |
13G/A
|
CBMX / CombiMatrix Corp.
|
|
290,000 |
0 |
|
|
|
2018-02-13 |
13G/A
|
CPIX / Cumberland Pharmaceuticals Inc.
|
|
1,083,469 |
1,306,911 |
|
|
|
2018-02-13 |
13G/A
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
1,644,591 |
1,694,717 |
|
|
|
2018-02-13 |
13G/A
|
ISEE / IVERIC bio Inc
|
|
2,292,900 |
2,350,000 |
|
|
|
2018-02-13 |
13G/A
|
REPH / Societal CDMO Inc
|
|
1,902,380 |
1,050,115 |
|
|
|
2018-02-13 |
13G/A
|
VCEL / Vericel Corporation
|
|
1,883,800 |
0 |
|
|
|
2018-02-13 |
13G/A
|
BBI / Brickell Biotech Inc
|
|
1,232,893 |
676,232 |
|
|
|
2018-02-12 |
13D/A
|
VIVE / Viveve Medical, Inc.
|
|
3,858,209 |
3,873,567 |
|
|
|
2018-02-09 |
13G
|
CFMS / Conformis Inc.
|
|
|
3,357,803 |
|
|
|
2018-01-22 |
13G
|
HTGM / HTG Molecular Diagnostics Inc
|
|
|
1,450,000 |
|
|
|
2018-01-12 |
13G/A
|
CTIC / CTI BioPharma Corp
|
|
2,150,000 |
2,150,000 |
|
|
|
2018-01-11 |
13G/A
|
CTIC / CTI BioPharma Corp
|
|
2,307,446 |
2,150,000 |
|
|
|
2017-12-21 |
13G
|
VYNT / Vyant Bio, Inc.
|
|
|
1,396,205 |
|
|
|
2017-12-18 |
13G
|
US0909311062 / BioSpecifics Technologies Corp.
|
|
|
375,000 |
|
|
|
2017-11-15 |
13G
|
BBI / Brickell Biotech Inc
|
|
1,232,893 |
1,232,893 |
|
|
|
2017-11-14 |
13G
|
BBI / Brickell Biotech Inc
|
|
|
1,232,893 |
|
|
|
2017-08-18 |
13G
|
APEN / Apollo Endosurgery Inc
|
|
|
2,364,707 |
|
|
|
2017-08-09 |
13G
|
CBMX / CombiMatrix Corp.
|
|
|
290,000 |
|
|
|
2017-06-22 |
13G
|
CTIC / CTI BioPharma Corp
|
|
|
2,307,446 |
|
|
|
2017-05-19 |
13D/A
|
VIVE / Viveve Medical, Inc.
|
|
3,856,046 |
3,858,209 |
|
|
|
2017-05-19 |
13G
|
CPIX / Cumberland Pharmaceuticals Inc.
|
|
|
1,083,469 |
|
|
|
2017-05-16 |
13G/A
|
REPH / Societal CDMO Inc
|
|
1,902,380 |
1,902,380 |
|
|
|
2017-05-15 |
13G/A
|
REPH / Societal CDMO Inc
|
|
2,874,317 |
1,902,380 |
|
|
|
2017-03-23 |
13D/A
|
VIVE / Viveve Medical, Inc.
|
|
|
3,856,046 |
|
|
|
2017-02-14 |
13G/A
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
|
1,644,591 |
|
|
|
2017-02-14 |
13G/A
|
ALIM / Alimera Sciences, Inc.
|
|
|
4,615,813 |
|
|
|
2017-02-14 |
13G/A
|
CRME / Cardiome Pharma Corp.
|
|
|
3,158,816 |
|
|
|
2017-02-14 |
13G/A
|
QLTI / The 2023 ETF Series Trust II - GMO International Quality ETF
|
|
|
1,644,591 |
|
|
|
2017-02-14 |
13G/A
|
SAVA / Cassava Sciences, Inc.
|
|
|
0 |
|
|
|
2017-02-14 |
13G/A
|
PTX / Pernix Therapeutics Holdings, Inc.
|
|
|
0 |
|
|
|
2017-02-14 |
13G/A
|
TRIB / Trinity Biotech plc - Depositary Receipt (Common Stock)
|
|
|
436,066 |
|
|
|
2017-02-14 |
13G/A
|
VCEL / Vericel Corporation
|
|
|
1,883,800 |
|
|
|
2017-01-13 |
13G
|
BDSI / Biodelivery Sciences International
|
|
|
3,228,493 |
|
|
|
2016-12-29 |
13G
|
ISEE / IVERIC bio Inc
|
|
|
2,292,900 |
|
|
|
2016-12-19 |
13G/A
|
REPH / Societal CDMO Inc
|
|
|
2,874,317 |
|
|
|
2016-01-26 |
13G/A
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
2,321,556 |
2,017,900 |
|
|
|
2015-07-02 |
13G
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
2,321,556 |
|
|
|